—An analysis of registry data concluded that hypersensitivity reactions in patients with mastocytosis are caused by exposure to certain triggers, including low tryptase levels and stings from certain ...

When confronted with chronic eczematous dermatitis, clinicians should try to differentiate between intrinsic (atopic dermatitis [AD]) and extrinsic (allergic or irritant contact dermatitis) causes. AD ...

Local anesthetics have transformed clinical practice by enabling a broad range of minor and major procedures with minimal discomfort. Although adverse reactions are frequently reported, genuine ...

1 Department of Microbiology & Immunology, The University of Melbourne, Parkville, Victoria 3010, Australia. An increasing number of HLA associations have been observed with drug-hypersensitivity ...

Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma Efficacy of ...

Patients treated with platinum compounds are subject to hypersensitivity reactions. Our study has highlighted the reactions related to oxaliplatin (OHP) infusion. One hundred and twenty-four patients ...

Please provide your email address to receive an email when new articles are posted on . According to the researchers, the chemotherapeutic agent paclitaxel is a commonly used taxane that includes ...

Credit: Getty Images. The IGIV and IGSC products were voluntarily withdrawn due to a higher rate of allergic/hypersensitivity type reactions, some of which were considered medically significant.

Georgina Jelley, a 28-year-old from London, revealed her battle with progesterone hypersensitivity, an allergy tied to her menstrual cycle. This condition, triggered by natural or supplemental ...

Symptoms usually occur between two and six weeks after drug administration and may subsequently recur, even after the person has stopped taking the offending drug. Drug-induced hypersensitivity ...

This study involved 3,708 patients with cancer, with an incidence of paclitaxel HSR of 10.11%. An 11-predictor–based Pac-HSR scoring system was developed, involving the following factors: younger age; ...